Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
This retrospective study collects and evaluates the clinical experience reached in Italy on the use of bendamustine alone or combined with rituximab as treatment of patients with relapsed or refractory chronic lymphoproliferative disorders.
Epistemonikos ID: f8218b720dd3b2d99b1e92f12b9a2a82a58ad2e3
First added on: May 06, 2024